RIPK3 and Sepsis: Though necroptosis was initially posited as a driver of multiple inflammatory pathologies, including sepsis, evidence of widespread necroptosis in septic humans is lacking, and the hope of limiting septic inflammation by narrowly targeting the RIPK1 or RIPK3 kinase domain is likely misplaced (27, 28).